Sungchae Hong

494 total citations
20 papers, 440 citations indexed

About

Sungchae Hong is a scholar working on Cancer Research, Surgery and Molecular Biology. According to data from OpenAlex, Sungchae Hong has authored 20 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Sungchae Hong's work include Cancer, Hypoxia, and Metabolism (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and High Altitude and Hypoxia (5 papers). Sungchae Hong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and High Altitude and Hypoxia (5 papers). Sungchae Hong collaborates with scholars based in South Korea, United States and Ethiopia. Sungchae Hong's co-authors include Yunjin Jung, Young Mi Kim, Mi‐Kyoung Kwak, Soohwan Yum, Jihye Kim, Yung-Jin Kim, Wooseong Kim, Jeong-Hyun Yoon, Song-Yi Han and Gunhyuk Park and has published in prestigious journals such as Analytical Biochemistry, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Sungchae Hong

20 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sungchae Hong South Korea	11	178	69	61	49	46	20	440
Kyu‐Shik Lee South Korea	14	222 1.2×	97 1.4×	47 0.8×	38 0.8×	51 1.1×	44	536
Truc Le Germany	8	124 0.7×	80 1.2×	24 0.4×	37 0.8×	52 1.1×	10	376
Hanis Hazeera Harith Malaysia	15	259 1.5×	51 0.7×	49 0.8×	67 1.4×	161 3.5×	34	655
Maralee McVean United States	9	209 1.2×	37 0.5×	36 0.6×	56 1.1×	66 1.4×	16	479
Mirela Baus Lončar Croatia	10	114 0.6×	74 1.1×	27 0.4×	21 0.4×	57 1.2×	21	369
Kyeong Eun Yang South Korea	13	214 1.2×	27 0.4×	26 0.4×	62 1.3×	40 0.9×	23	441
Gülfer Öztürk Türkiye	11	113 0.6×	139 2.0×	23 0.4×	42 0.9×	43 0.9×	27	460
Ornella Avanti Switzerland	9	232 1.3×	44 0.6×	50 0.8×	20 0.4×	27 0.6×	9	599
Kyung-Yun Kang South Korea	14	152 0.9×	35 0.5×	31 0.5×	22 0.4×	74 1.6×	39	494
Samar F. Darwish Egypt	12	167 0.9×	31 0.4×	89 1.5×	76 1.6×	48 1.0×	20	437

Countries citing papers authored by Sungchae Hong

Since Specialization

Citations

This map shows the geographic impact of Sungchae Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sungchae Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sungchae Hong more than expected).

Fields of papers citing papers by Sungchae Hong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sungchae Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sungchae Hong. The network helps show where Sungchae Hong may publish in the future.

Co-authorship network of co-authors of Sungchae Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Sungchae Hong. A scholar is included among the top collaborators of Sungchae Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sungchae Hong. Sungchae Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hong, Sungchae, Sanghyun Ju, Jin‐Wook Yoo, Nam‐Chul Ha, & Yunjin Jung. (2021). Design and evaluation of IKK-activated GSK3β inhibitory peptide as an inflammation-responsive anti-colitic therapeutic. Biomaterials Science. 9(19). 6584–6596. 5 indexed citations

Park, Gunhyuk, et al.. (2014). Walnuts (Seeds of Juglandis sinensis L.) Protect Human Epidermal Keratinocytes against UVB-Induced Mitochondria-Mediated Apoptosis through Upregulation of ROS Elimination Pathways. Skin Pharmacology and Physiology. 27(3). 132–140. 28 indexed citations

Jeong, Seongkeun, et al.. (2014). Lipophilic modification enhances anti-colitic properties of rosmarinic acid by potentiating its HIF-prolyl hydroxylases inhibitory activity. European Journal of Pharmacology. 747. 114–122. 15 indexed citations

Lee, Yonghyun, Wooseong Kim, Sungchae Hong, et al.. (2014). Colon-targeted celecoxib ameliorates TNBS-induced rat colitis: A potential pharmacologic mechanism and therapeutic advantages. European Journal of Pharmacology. 726. 49–56. 15 indexed citations

Yum, Soohwan, et al.. (2013). N-(2-mercaptopropionyl)-glycine, a diffusible antioxidant, activates HIF-1 by inhibiting HIF prolyl hydroxylase-2: Implication in amelioration of rat colitis by the antioxidant. Biochemical and Biophysical Research Communications. 443(3). 1008–1013. 4 indexed citations

Kim, Hyun‐Jeong, Wooseong Kim, Soohwan Yum, et al.. (2013). Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: Structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radical Biology and Medicine. 65. 552–562. 49 indexed citations

Yum, Soohwan, Sungchae Hong, Seongkeun Jeong, et al.. (2012). Piceatannol, a hydroxystilbene natural product, stabilizes HIF-1α protein by inhibiting HIF prolyl hydroxylase. European Journal of Pharmacology. 699(1-3). 124–131. 18 indexed citations

Hong, Sungchae, Soohwan Yum, Hyun‐Jung Yoo, et al.. (2012). Colon-Targeted Cell-Permeable NFκB Inhibitory Peptide Is Orally Active against Experimental Colitis. Molecular Pharmaceutics. 9(5). 1310–1319. 45 indexed citations

Yum, Soohwan, Sungchae Hong, Myung Hee Park, et al.. (2011). Hyperoxia attenuates the inhibitory effect of nitric oxide donors on HIF prolyl-4-hydroxylase-2: Implication on discriminative effect of nitric oxide on HIF prolyl-4-hydroxylase-2 and collagen prolyl-4-hydroxylase. Biochemical Pharmacology. 82(5). 485–490. 1 indexed citations

10.

Kim, Jihye, et al.. (2011). Structure–activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis. European Journal of Medicinal Chemistry. 48. 36–44. 13 indexed citations

11.

Kong, Hyesik, Yonghyun Lee, Hyun‐Jeong Kim, et al.. (2011). Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site. Journal of Pharmacy and Pharmacology. 64(1). 128–138. 6 indexed citations

12.

Kong, Hyesik, Yonghyun Lee, Sungchae Hong, et al.. (2011). Structural effects of N‐aromatic acyl‐amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon‐specific prodrug with controlled conversion rate at the target site. Biopharmaceutics & Drug Disposition. 32(6). 343–354. 3 indexed citations

13.

Kim, Jihye, et al.. (2010). Caffeic acid phenethyl ester-mediated Nrf2 activation and IκB kinase inhibition are involved in NFκB inhibitory effect: Structural analysis for NFκB inhibition. European Journal of Pharmacology. 643(1). 21–28. 129 indexed citations

14.

Hong, Sungchae, Soohwan Yum, Nam‐Chul Ha, & Yunjin Jung. (2010). von Hippel–Lindau β-domain–luciferase fusion protein as a bioluminescent hydroxyproline sensor for a hypoxia-inducible factor prolyl hydroxylase assay. Analytical Biochemistry. 407(2). 220–225. 3 indexed citations

15.

Hong, Sungchae, et al.. (2009). Synthesis and Evaluation of N-Nicotinoyl-2-{2-(2-Methyl-5-Nitroimidazol-1-yl)Ethyloxy}-D,L-Glycine as a Colon-Specific Prodrug of Metronidazole. Journal of Pharmaceutical Sciences. 98(11). 4161–4169. 9 indexed citations

16.

Han, Song-Yi, et al.. (2009). Caffeic acid phenethyl ester is a potent inhibitor of HIF prolyl hydroxylase: structural analysis and pharmacological implication. The Journal of Nutritional Biochemistry. 21(9). 809–817. 30 indexed citations

17.

Hong, Sungchae, et al.. (2009). An anti-inflammatory mechanism of taurine conjugated 5-aminosalicylic acid against experimental colitis: Taurine chloramine potentiates inhibitory effect of 5-aminosalicylic acid on IL-1β-mediated NFκB activation. European Journal of Pharmacology. 618(1-3). 91–97. 22 indexed citations

18.

Kong, Hyesik, et al.. (2009). Sulfate-conjugated methylprednisolone as a colon-targeted methylprednisolone prodrug with improved therapeutic properties against rat colitis. Journal of drug targeting. 17(6). 450–458. 10 indexed citations

19.

Lee, Jong-Suk, et al.. (2009). Manganese (II) induces chemical hypoxia by inhibiting HIF-prolyl hydroxylase: Implication in manganese-induced pulmonary inflammation. Toxicology and Applied Pharmacology. 235(3). 261–267. 25 indexed citations

20.

Kim, Inho, Hyesik Kong, Younghyun Lee, et al.. (2008). Dexamethasone 21-Sulfate Improves the Therapeutic Properties of Dexamethasone Against Experimental Rat Colitis by Specifically Delivering the Steroid to the Large Intestine. Pharmaceutical Research. 26(2). 415–421. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact